Philipp Müller

A therapeutic vaccine for nicotine dependence: preclinical efficacy, and phase I safety and immunogenicity

Patrik Maurer, Gary T. Jennings, Jörg Willers et al. · European Journal of Immunology · 2005 · 280 citations · Full text

Medicine, Immunology, Pharmacology +17

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity

Patrice M. Ambühl, Alain C. Tissot, Alma Fulurija et al. · Journal of Hypertension · 2006 · 219 citations

Veterinary Medicine, Cardiology, Immunology +17

Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes

Claudia Cavelti‐Weder, Katharina Timper, Eleonora Seelig et al. · Molecular Therapy · 2015 · 73 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome

Philipp Müller, Oscar Velázquez Camacho, Ali M. Yazbeck et al. · Computational and Structural Biotechnology Journal · 2023 · 37 citations · Full text

Life Sciences, Cancer Biology, Genetics +17

Sodium fluoride-induced gastric mucosal lesions: comparison with sodium monofluorophosphate.

Philipp Müller, K. W. Schmid, G. Warnecke et al. · PubMed · 1992 · 17 citations

Medicine, Pharmacology, Toxicology +16